*|MC:SUBJECT|*
bioRN News October 2026
Dear *|FNAME|* *|LNAME|*,

A growing network – and more ways to connect

Our bioRN community continues to grow! With 190 members, our network brings together an increasingly diverse range of expertise, perspectives and opportunities for collaboration across the Rhine-Main-Neckar life science ecosystem.

As our network grows, so does the importance of creating opportunities for meaningful exchange. Through our bioRN Pharma Circle, C-Level Circle, Investment Circle and MarCom Community, we bring together people with shared interests and challenges to discuss specific topics, exchange experiences and learn from one another.

At the same time, formats such as our bioRN Lounge and life - the biomedical convention 2027 bring the wider life science community together – across disciplines, organisations and sectors. Both are important to us: focused discussions within specific communities and open encounters that create connections beyond them.

October offered plenty of examples of both.

Our C-Level Circle, hosted by PROGEN, explored how companies can attract and retain talent, with trust emerging as one of the key takeaways. At our first bioRN MarCom Summit, 50 marketing and communications professionals shared insights and practical experiences around targeted communication. And in our latest Member-to-Member interview, NMI demonstrated how specialised research expertise can support pharmaceutical drug development. Find the video on our Youtube-Channel.

We also connected beyond our regional network. At the Festival of Biologics in Basel, bioRN was represented with an exhibition booth, while our October bioRN Lounge welcomed a delegation from Occitanie and Montpellier alongside Prof. Matthias Rädle's insights into spectroscopic process control and biomedical applications.

And there is plenty to look forward to!

Meet bioRN in November:

  • 9-11 Nov.: meet bioRN at the BIO Europe: Together with BIOPRO Baden Württemberg and partners, bioRN Life Science Cluster will be represented at the "THE LÄND" booth. Let's meet in Cologne! 📍 Hall 7.1 | Booth 21A 
    We look forward to connecting with you!
     
  • 24 Nov. 6pm: bioRN Lounge @ Urban Kitchen Heidelberg: We are looking forward to welcoming Prof. Dr. Frauke Gräter, Director Max Planck Institute for Polymer Research, Uni Mainz with her talk: >>Under Pressure: How Connective Tissue Responds to Stress and Aging<< . Registration is open.
  • 26. Nov. 9-10:30am digital (Zoom): bioRN Webinar: Clinical Development Unlocked - A roadmap from research to clinical products -current insights on strategies, costs and challenges from bioRN members. More Information and Registration here
1 Dec. 2026: We are preparing a special occasion: our upcoming  ordinary Members' Assembly of BioRN Network e.V., celebrating 30 years of bioRN Life Science Cluster.
Three decades of connecting science, industry and people across our region – certainly a reason to celebrate. We look forward to an entertaining evening with our members!

3. Feb. 2027: The program for life - the biomedical convention 2027 continues to take shape, with more speakers confirmed, including Prof. Dr. Michael Hölzel and Niels Emmerich. On 3 February 2027 in Heidelberg, we will once again bring together our life science ecosystem for a day of scientific insights, new perspectives and opportunities to connect. Our discounted ticket rate is available until 30 November, and only 10 exhibition booths remain. So don't wait too long to secure your place!

 

Enjoy our October newsletter!

Don´t miss further news and events which you will find at the bioRN website.
We look forward to seeing you soon!

Kind regards,

Stephanie Füller 
PR Manager
bioRN Life Science Cluster 
LinkedIn
Twitter
Website
01 | Research Highlights & News
02 | New Members
03 | Opportunities
04 | Event Spotlights
05 | Event Calendar & Discounts
06 | Open Positions
01 | Research Highlights & News

BioMed X  Launches New Neuroscience Research Team to Investigate Anhedonia [more]

BioMaterialBank Heidelberg:  Newsletter der BMBH: Biobanking Update! [more]

Cell Signaling Technology:
  • Huntington’s Disease Biomarkers: Key Molecular Targets and Antibody Tools for HD Research [more]
  • CST Announces Availability of GMP-Grade CAR Linker Antibodies for CAR-T Cell Enrichment and Detection in Clinical Manufacturing and QC [more]
  • How the Inflammasome Drives Disease: Tackling Aberrant Inflammasome Signaling [more]

DKFZ:
  • Highly Sensitive Detection of MRI Contrast Agents [more]
  • Four Million Euros in EU Funding to Improve Prostate Cancer Care [more]
  • Healthy Lifestyle – Lower Cancer Risk: Large Study Confirms and Expands Association for Numerous Types of Cancer [more]
EMBL:
  • AlphaFold Database adds viral protein complexes to support pandemic preparedness [more]
  • European Commission grants €57 million to critical open data resources [more]
Hummingbird Diagnostic:
  • Hummingbird Diagnostics Showcases New Data Utilizing Blood-Based Small RNA for Lung Cancer Treatment Monitoring at ESMO Congress 2026 [more]
  • Hummingbird Diagnostics to Present Blood-Based RNA Biomarker Data in Stage III Lung Cancer at ESMO 2026 [more]

Max Planck Institute for Medical Research:
  • Harnessing Synthetic Cellular Systems as Immune Cell Boosters [more]
  • Sarel Fleishman receives the Otto Meyerhof Medal [more]
NMI - Natural and Medical Sciences Institute at the University of Tübingen:
  • Diaper Recycling: Progress Even Among the Market Leader [more]

Sanofi breaks ground on new state-of-the-art insulin manufacturing facility in Germany [more]

UKHD:
  • From microscopy to AI: Andreas von Deimling shaped modern brain tumor diagnostics in Heidelberg [more]
  • A Matter of Quantity: A Universal Target for CAR-T Cells Against Cancer [more]
  • Greater Precision and Safety in Neurosurgical Procedures [more]

Universität Heidelberg:
  • Synthetic Cells: Function Through Mutation  [more]

02 | New Members

aiPTO is an official spin-off from the German Cancer Research Center (DKFZ) developing an AI-powered technology platform that combines next-generation patient avatars with generative AI to improve preclinical brain cancer research. Its mission is to overcome the limitations of existing models and enable more effective, personalized treatments for primary and metastatic brain tumors.
Exciva was founded in 2016 to address neuropsychiatric symptoms in AD dementia and other brain disorders. It uses its powerful discovery potential, which has led to the combination of two CNS-active compounds, to treat agitation in patients living with AD dementia. Exciva is based in Heidelberg, Germany and closed the most recent Series B financing round in 2025. Their lead product received a Fast Track designation from the US FDA and is currently in phase 2/3 clinical trial in people with agitation / aggression due to Alzheimer’s disease dementia (clinical sites in the EU, UK, US and Canada).
Peptide Specialty Laboratories (PSL) GmbH specialises in the synthesis of bespoke peptides and the production of peptide-specific antibodies. PSL was founded in Heidelberg in 2000 as a spin-off from the German Cancer Research Centre (DKFZ). Since then, we have been based in the Heidelberg Technology Park and serve customers from our immediate vicinity as well as hundreds of clients from the industrial and academic research sectors in over 35 countries.

03 | Opportunities


In this section we provide selected information on funding calls and events. On our website in the section startup support you will find a calendar with more Open Calls, Pitches, Knowledge Transfer and Closings.

Open Calls:  

  • The GeneNovate® 2027 (Nationale Strategie Gen-und Zellbasierte Therapien) Call for Applications is now open!   more
Knowledge Transfer:  
  • From lab to market: aligning IP with investment and growth, Seminar 17 November [more]
  • BRIGHT skills University Seminar: 17-19.Nov.: Supply chain Management : more 

04 | Event Spotlights

SAVE THE DATE /NEW EVENTS

05 | Event Calendar & Discounts

„Welcome Sessions – German Social Security Made Easy” | Webinar, Techniker Krankenkasse
Every 1st Thursday of the Month - Online >>

 
Start-ups meet xTech – Von Daten zu Innovationen. Von Modellen zu Therapien
November 02, 2026 - Göppingen, Germany >>

 
5-HT Innovators Club Conference
November 05, 2026 - Heidelberg, Germany >>

 
Falling Walls 
November 06-9, 2026 - Berlin, Germany >>
Discount Tickets for bioRN members

for more information contact Alexya Azhakesan  (aa@biorn.org)

 
Bio-Europe 2026
November 09-11, 2026 - Köln, Germany >>
12% Discount for Members!
Logo display at the The Länd booth: BioRN Members that visit Bio-Europe may display their logo at The Länd booth. For more information please contact Nicole Hecht (nh(at)biorn.org).


 
bioRN M2M Member to Member featuring Cell Signaling Technologies
November 17, 2026 - Online >>

 
bioRN Lounge with Dr. Frauke Gräter (Under Pressure: How Connective Tissue Responds to Stress and Aging)
November 14, 2026 - Heidelberg, Urban Kitchen >>

 
Webinar: Clinical Development Unlocked – A roadmap from research to clinical products -current insights on strategies, costs and challenges from BioRN members
November 26, 2026 - Online >>

 
Targeted Drug Delivery | 5th Joint Meeting of GBM & BioPharma Cluster South German
November 27, 2026 - Ulm, Germany >>

 
BioFIT and MedFIT 2026
December 10-11, 2026 - Marseille, France >>
20 % Discount for Members!

 
Trade Mission to Indonesia – MedTech | Registration Deadline
September 13-17, 2027 - Indonesia >>
Registration Deadline: February 01, 2027


 
Save-the-Date: Aktuelle Trends im Biomanufacturing - Erfolgsmodell Kooperation
February 24-25, 2027 - Ulm, Germany
More Infos will follow :)
Curious 2027 comes to HEIDELBERG
July 07-08, 2027 - Heidelberg, Germany  >>
20 % Discount for Members!

06 | Open Positions


AIPTO TechBio: 
  • Data Engineer / Scientist – Multimodal Clinical Data Integration & AI (m/f/d) [more]
Cytion: 
  • Biologe / Content Creator (m/w/d) als Content Editor Life Science  [more]
Tweet Tweet
Forward Forward
Share Share

Imprint


Copyright © *|CURRENT_YEAR|* *|LIST:COMPANY|*, All rights reserved.
*|IFNOT:ARCHIVE_PAGE|* *|LIST:DESCRIPTION|*

Responsible for the content:
Dr. Julia Schaft

Editor: Stephanie Füller

Our mailing address is:
*|HTML:LIST_ADDRESS_HTML|* *|END:IF|*

Commercial Register: Mannheim, HRB 704801
VAT ID: DE 2630 64 014

unsubscribe from this list    update subscription preferences 

*|IF:REWARDS|* *|HTML:REWARDS|* *|END:IF|*